Food
INVESTORS
home > INVESTORS > Financial Information drop
IR Contact

Financial Information

We introduce ADBIOTECH’s technology intended to replace vaccines and antibiotics.

Sales

Operating profit

Net profit

Income Statements(Unit: KRW in thousands)

Item 2019 2020 2021
Sales 9,343,575 9,855,191 11,711,552
Cost Of Sales 4,858,235 4,420,793 4,927,141
Operating profit 102,140 -924,375 -1,482,585
Non-operating income 298,735 216,651 191,117
Non-operating expense 2,219,731 6,696,842 1,052,577
Net profit -1,705,828 -7,273,246 -2,593,815

Total Assets

Total liabilities

Total equity

Financial Position(Unit: KRW in thousands)

Item 2019 2020 2021
Current Assets 5,856,573 7,139,444 8,678,834
Non-current Assets 6,058,957 11,753,030 12,445,478
Total Assets 11,915,531 18,892,474 21,124,312
Current liabilities 12,748,080 5,471,936 12,654,295
Non-Current liabilities 70,138 4,017,721 3,227,821
Total liabilities 12,818,217 9,489,657 15,882,117
Share capital 822,893 1,267,337 3,846,522
Capital surplus 2,972,978 20,582,470 18,292,579
Retained earnings -6,335,658 -13,534,319 -16,128,134
Total equity -902,687 9,402,817 5,242,196